ENANTA PHARMACEUTICALS, INC Other Significant Noncash Transaction, Value of Consideration Given
ENANTA PHARMACEUTICALS, INC (ENTA) reported Other Significant Noncash Transaction, Value of Consideration Given of $1.47 million for the 6-month period ending 2013-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2014-12-11
- ENANTA PHARMACEUTICALS, INC other significant noncash transaction, value of consideration given for the quarter ending 2013-03-31 was $840.00K.
- ENANTA PHARMACEUTICALS, INC other significant noncash transaction, value of consideration given for the quarter ending 2012-12-31 was $626.00K.
- ENANTA PHARMACEUTICALS, INC other significant noncash transaction, value of consideration given for the quarter ending 2012-09-30 was $242.00K.
- ENANTA PHARMACEUTICALS, INC other significant noncash transaction, value of consideration given for fiscal 2012 was $1.08M.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 6 month | Other Significant Noncash Transaction, Value of Consideration Given 9 month | Other Significant Noncash Transaction, Value of Consideration Given 12 month |
|---|---|---|---|---|
| 2013-03-31 | $840.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $1.47M 10-Q · filed 2014-05-12 | $1.71M derived: sum of 3 quarters · filed 2014-12-11 | |
| 2012-12-31 | $626.00K 10-Q · filed 2014-02-13 | $868.00K derived: sum of 2 quarters · filed 2014-12-11 | ||
| 2012-09-30 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $1.08M 10-K · filed 2014-12-11 | ||
| 2012-06-30 | $837.00K 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |